Discover the latest news from the Pulmonary Hypertension, including advocacy updates, research articles and event coverage.
Mark Lung Transplant Awareness Day with free educational resources, patient stories, social media graphics, and a free book download.
News
People with pulmonary hypertension face higher risks from flu and COVID-19. Stay protected by getting recommended vaccines this fall.
News
Sickle Cell and Pulmonary Fibrosis Awareness Month highlights how associated conditions can increase the risk of pulmonary hypertension.
News
Hear from leading PH experts at PHA’s PH Wellness Expo in San Francisco, with exhibits, advocacy sessions and family fun.
Events | News
The new issue of Pathlight is here. Explore inspiring stories in PHA’s quarterly magazine, available online and by mail.
News
People with pulmonary hypertension face greater risks from air pollution. Learn symptoms, risks and prevention tips.
News
The settlement follows a September 2026 federal court ruling in favor of United Therapeutics regarding two patent infringement claims related to the use of inhaled treprostinil for PH-ILD. No safety concerns were raised.
The label references trial data that shows the drug as safe and effective for moderate to high-risk PAH.
Pulmovant is enrolling participants in its Phase 3 mosliciguat study after positive Phase 2 results.
